Differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma using magnetic resonance imaging: The value of contrast-enhanced and diffusion weighted imaging

Abstract

// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Chuangen Guo1, *, Xiao Chen2, 3, *, Zhongqiu Wang2, Wenbo Xiao1, Qidong Wang1, Ke Sun4 and Xiaoling Zhuge5 1Department of Radiology, The First Affiliated Hospital, College of Medicine Zhejiang University, Hangzhou 310003, China 2Department of Radiology, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 2100029, China 3Division of Nephrology, Zhongshan Hospital Fudan University, Shanghai 200032, China 4Department of Pathology, The First Affiliated Hospital, College of Medicine Zhejiang University, Hangzhou 310003, China 5Department of Laboratory Medicine, The First Affiliated Hospital, College of Medicine Zhejiang University, Hangzhou 310003, China *These authors have contributed equally to this work Correspondence to: Xiaoling Zhuge, email: xlzhgzy@qq.com Chuangen Guo, email: zyyfy001@sina.cn Keywords: pancreatic ductal adenocarcinoma, pancreatic neuroendocrine carcinoma, magnetic resonance imaging, diffusion-weighted imaging Received: December 28, 2016 Accepted: April 05, 2017 Published: April 21, 2017